Niagen Bioscience (NAGE) formerly ChromaDex Corp announced the broadening of its NAD+ precursor intellectual property or IP portfolio with the ...
This patent, exclusively licensed from Queen’s University Belfast, strengthens Niagen Bioscience’s position in the market for NAD+ precursors, substances that are critical for cellular health ...
CNBC on MSN10d
NAD+ infusion is the latest trendy anti-aging treatment: ‘We just don't know if there's any benefit,' longevity doctor saysNAD infusions are just one of the latest crazes for longevity-seekers, but can it really help you live longer? Here’s what an ...
Recent research has homed in on diet and exercise as key factors when it comes to slowing down biological aging and boosting ...
ChromaDex reports revenue growth with Niagen leading success, despite risks, its e-commerce surge and profits signal potential. Click to read why CDXC is a Hold.
Supplementing NAD+ precursors can help to increase production ... We know that some [infusions] may increase the NAD in the bloodstream, but not in the cell as much." Sirtuins is a group of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback